Vitamin D and Screening Colonoscopy or Polyp Surveillance
| Status: | Completed |
|---|---|
| Conditions: | Colorectal Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | August 2014 |
| End Date: | November 2015 |
Association of 25-OH Vitamin D Status With Findings on Screening Colonoscopy.
The investigators will recruit DoD beneficiaries 18 years or older, that have been referred
for a screening colonoscopy or polyp surveillance (or had one in the last 2 weeks), and have
no previous diagnosis of colorectal cancer. They will have a 25 OH Vitamin D level drawn to
determine if there is an association between the level obtained and findings on colonoscopy,
or previous findings (if repeating).
for a screening colonoscopy or polyp surveillance (or had one in the last 2 weeks), and have
no previous diagnosis of colorectal cancer. They will have a 25 OH Vitamin D level drawn to
determine if there is an association between the level obtained and findings on colonoscopy,
or previous findings (if repeating).
DoD beneficiaries age 18 or older will be recruited from the clinics at the Mike O'Callaghan
Federal Medical Center (MOFMC). Subjects meeting the inclusion/exclusion criteria will be
offered an opportunity to participate:
Screening Visit:
- Obtain signed Informed Consent Document and HIPAA Authorization (research-driven).
- Record: Date of birth, age, gender, race, ethnicity, current email address, height (in
inches), weight (in pounds), waist circumference (in inches) measurement, blood
pressure, and whether subject is taking or has taken any vitamin D supplement or
derivative, and if so, note the dosage, frequency, and duration of therapy.
- Subjects will be told to fast for at least 10 hours prior to Visit 1
Visit 1 (within two weeks of their screening colonoscopy):
-Subjects will have the following research-driven blood test drawn which include: Serum
25-OH vitamin D via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be
drawn)
Federal Medical Center (MOFMC). Subjects meeting the inclusion/exclusion criteria will be
offered an opportunity to participate:
Screening Visit:
- Obtain signed Informed Consent Document and HIPAA Authorization (research-driven).
- Record: Date of birth, age, gender, race, ethnicity, current email address, height (in
inches), weight (in pounds), waist circumference (in inches) measurement, blood
pressure, and whether subject is taking or has taken any vitamin D supplement or
derivative, and if so, note the dosage, frequency, and duration of therapy.
- Subjects will be told to fast for at least 10 hours prior to Visit 1
Visit 1 (within two weeks of their screening colonoscopy):
-Subjects will have the following research-driven blood test drawn which include: Serum
25-OH vitamin D via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be
drawn)
THIS STUDY IS BEING CONDUCTED AT A MILITARY INSTALLATION. YOU MUST HAVE MILITARY INSURANCE
IN ORDER TO PARTICIPATE IN THIS STUDY.
Inclusion:
- DoD beneficiaries 18 years or older
- Referred for a screening colonoscopy or polyp surveillance or had one in the last 2
weeks
Exclusion:
- Previous diagnosis of colorectal cancer, adenomatous polyps, and/or cancer
- Military trainees
- Pregnant women
We found this trial at
1
site
Click here to add this to my saved trials
